Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. [Phase 2]

View source ↗

Summary

This document reports results from a Phase 2 study of bevacizumab (Avastin) in combination with standard therapy for patients with metastatic renal cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-13